<?xml version="1.0" encoding="UTF-8"?>
<p>There are barriers to performing outpatient trials that must be solved. First, to implement a scalable early treatment strategy, widely available testing is needed. Home testing with self-sampling allows rapid diagnosis within 1 day of developing symptoms and avoids the need for personal protective equipment (PPE) utilization by healthcare staff. The US food &amp; drug administration recently granted approval for home testing. Given the public health benefits of isolating cases, studies are making this available to citizens in cities with high burden of infection [
 <xref rid="CIT0024" ref-type="bibr">24</xref>]. Self-quarantine will be more likely if people know they are infected, particularly given the economic incentive to continue working despite mild symptoms.
</p>
